The fresh names being added to the hall of fame include an aviation medicine specialist, as well as researchers who made important contributions to cardiology and neurology.
Ryaltris was approved for symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms in people over six years old.